Samarium-153 lexidronam for painful bone metastases

Medical Letter on Drugs and Therapeutics

Volumn 39, Issue 1008, 1997, Pages 83-84

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

LEXIDRONAM; LEXIDRONAM SAMARIUM SM 153; SAMARIUM 153; STRONTIUM 89; UNCLASSIFIED DRUG;

BONE METASTASIS; BONE PAIN; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; SHORT SURVEY;

ANALGESICS, NON-NARCOTIC; BONE NEOPLASMS; CLINICAL TRIALS; COSTS AND COST ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; PAIN; PALLIATIVE CARE; RADIOISOTOPES; SAMARIUM;

EID: 0030930578     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (9)

1. Medical Letter, 35:102, 1993
2. A Ahonen et al, J Nucl Biol Med, 38 suppl 1:123, 1994
3. JE Bayouth et al, J Nucl Med, 35:63, 1994; JF Eary et al, J Nucl Med, 34:1031, 1993; JH Turner et al, J Clin Oncol, 7:1926, 1989
4. JE Bayouth et al, J Nucl Med, 35:63, 1994; JF Eary et al, J Nucl Med, 34:1031, 1993; JH Turner et al, J Clin Oncol, 7:1926, 1989
5. JE Bayouth et al, J Nucl Med, 35:63, 1994; JF Eary et al, J Nucl Med, 34:1031, 1993; JH Turner et al, J Clin Oncol, 7:1926, 1989
6. C Collins et al, J Nucl Med, 34:1839, 1993
7. A Serafini et al, J Nucl Med, 37[5]:32P, 1996
8. O Sartor et al, J Urol, 157 suppl:321, April 1997
9. AS Alberts et al, Radiother Oncol, 43:175, 1997